23 May 2013
Keywords: proximagen, licenses, candidate, cns, drugs, uk-based, drug
Article | 05 June 2006
UK-based drug discovery group Proximagen Neuroscience says that it has signed an exclusive in-licensing agreement for a suite of drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 June 2006
© 2013 thepharmaletter.com